Skip to main content
Premium Trial:

Request an Annual Quote

Nat Goodman, Rob Williamson


The Institute for Systems Biology in Seattle has hired Nat Goodman as senior research scientist. Goodman joins ISB after a stint as a freelance bioinformatics consultant. Prior to that, he was senior vice president at Cambridge, Mass.-based 3rd Millennium. Goodman will also have an appointment at the University of Alaska, Fairbanks, as affiliate professor of bioinformatics at the Arctic Region Supercomputing Center. He will continue to write his monthly “IT Guy” column for BioInform’s sister publication, Genome Technology.

Former DoubleTwist CEO Rob Williamson has landed a new job as president and COO of South San Francisco-based Eos Biotechnology.

Williamson was promoted from president to CEO of DoubleTwist in January 2002 in an unsuccessful bid to salvage the company, which closed it doors in March.

Eos CEO David Martin cited Wiliamson’s “business development, financial, and operating experience” as strengths that would aid the company’s efforts to move its pipeline of therapeutic antibodies toward the clinic.

Filed under

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.